Augmedix, Inc. (AUGX) Financial Statements (2023 and earlier)

Company Profile

Business Address 111 SUTTER STREET, SUITE 1300
SAN FRANCISC, CA 94104
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 7389 - Business Services, Not Elsewhere Classified (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments19,91421,25126,25129,98836,65241,255
Cash and cash equivalents19,91421,25126,25129,98836,65241,255
Restricted cash and investments125125125125125125
Receivables6,3146,3545,0534,6974,2097,178
Other undisclosed current assets2,0071,8201,5311,6041,6801,868
Total current assets:28,36029,55032,96036,41442,66650,426
Noncurrent Assets
Operating lease, right-of-use asset1,8631,5671,7381,9072,074 
Property, plant and equipment1,6861,5731,3031,1631,259982
Restricted cash and investments600612621665  
Other undisclosed noncurrent assets558339527414275275
Total noncurrent assets:4,7074,0914,1894,1493,6081,257
TOTAL ASSETS:33,06733,64137,14940,56346,27451,683
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,8556,8848,9227,3495,7145,624
Employee-related liabilities2,7552,0931,408 
Accounts payable2,1291,5631,4171,5841,4011,365
Accrued liabilities3,7265,3214,7503,6722,9054,259
Deferred revenue6,9157,2546,3885,8635,2616,238
Debt 2,5003,7501,875 3,0001,500
Customer refund liability 524554595632632632
Other undisclosed current liabilities991872(1,889)(1,233)(555) 
Total current liabilities:16,78519,31415,89112,61114,05213,994
Noncurrent Liabilities
Long-term debt and lease obligation18,85512,35214,32616,29813,550 
Long-term debt, excluding current maturities18,85512,35214,32616,29813,550 
Liabilities, other than long-term debt 482   273
Deferred rent credit      273
Lease deposit liability  482    
Operating lease, liability      
Other undisclosed noncurrent liabilities6152748148749613,732
Total noncurrent liabilities:19,47012,86114,80716,78514,04614,005
Total liabilities:36,25532,17530,69829,39628,09827,999
Equity
Equity, attributable to parent(3,188)1,4666,45111,16718,17623,684
Common stock444444
Additional paid in capital128,311127,693126,966126,485125,916125,479
Accumulated other comprehensive loss(473)(440)(327)(210)(79)(70)
Accumulated deficit(131,030)(125,791)(120,192)(115,112)(107,665)(101,729)
Total equity:(3,188)1,4666,45111,16718,17623,684
TOTAL LIABILITIES AND EQUITY:33,06733,64137,14940,56346,27451,683

Income Statement (P&L) ($ in thousands)

6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
Revenues9,6288,7517,8647,3336,9856,577
Cost of revenue(5,242)(4,702)(4,274)(4,131)(3,872)(3,640)
Gross profit:4,3864,0493,5903,2023,1132,937
Operating expenses(9,480)(9,489)(9,048)(9,253)(8,558)(7,764)
Operating loss:(5,094)(5,440)(5,458)(6,051)(5,445)(4,827)
Nonoperating expense(112)(48)(32)(1,396)(491)(624)
Investment income, nonoperating16217759457
Other nonoperating income (expense)13414822582105(18)
Interest and debt expense(100)(897)(100)(100)(200)(2,859)
Loss from continuing operations before equity method investments, income taxes:(5,306)(6,385)(5,590)(7,547)(6,136)(8,310)
Other undisclosed income from continuing operations before income taxes1001,097    
Loss from continuing operations before income taxes:(5,206)(5,288)(5,590)(7,547)(6,136)(8,310)
Income tax expense(33)     
Other undisclosed loss from continuing operations  (111)   (977)
Loss from continuing operations:(5,239)(5,399)(5,590)(7,547)(6,136)(9,287)
Loss before gain (loss) on sale of properties:(5,590)(7,547)(6,136)(9,287)
Other undisclosed net income      1,656
Net loss:(5,239)(5,399)(5,590)(7,547)(6,136)(7,631)
Net loss attributable to noncontrolling interest    (7,400)(5,900)(5,500)
Other undisclosed net income (loss) attributable to parent  (200)1007,5006,1007,680
Net loss available to common stockholders, diluted:(5,239)(5,599)(5,490)(7,447)(5,936)(5,451)

Comprehensive Income ($ in thousands)

6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
Net loss:(5,239)(5,399)(5,590)(7,547)(6,136)(7,631)
Other comprehensive income33 117   
Other undisclosed comprehensive income (loss)(66)(313)(134)(31)1912,156
Comprehensive loss:(5,272)(5,712)(5,607)(7,578)(5,945)(5,475)
Comprehensive loss, net of tax, attributable to noncontrolling interest    (7,400)(5,900)(5,500)
Comprehensive loss, net of tax, attributable to parent:(5,272)(5,712)(5,607)(14,978)(11,845)(10,975)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: